Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

Marina Chiara Garassino(Fondazione IRCCS Istituto Nazionale dei Tumori), Byoung Chul Cho(Yonsei University), Joo-Hang Kim(CHA University Bundang Medical Center), Julien Mazières(Université Toulouse III - Paul Sabatier), Johan Vansteenkiste(KU Leuven), H. Léna(Oncogenesis Stress Signaling), Jesus Corral Jaime(Hospital Universitario Virgen del Rocío), Jhanelle E Gray(Moffitt Cancer Center), John D. Powderly(Carolina BioOncology Institute), C. Chouaïd(Inserm), Paolo Bidoli(Azienda Ospedaliera San Gerardo), Paul Wheatley‐Price(University of Ottawa), Keunchil Park(Samsung Medical Center), Ross A. Soo(National University Cancer Institute, Singapore), Yifan Huang(AstraZeneca (United States)), Catherine Wadsworth(AstraZeneca (United Kingdom)), Phillip A. Dennis(AstraZeneca (United States)), Naiyer A. Rizvi(Columbia University Irving Medical Center), Luis Paz-Ares Rodríguez, Silvia Novello(University of Turin), Sandrine Hiret(Institut de Cancérologie de l'Ouest), Peter Schmid(Imperial College London), Eckart Laack, Raffaele Califano, Makoto Maemondo, Sang‐We Kim(CHA University Bundang Medical Center), Jamie E. Chaft, David Vicente Baz, Thierry Berghmans(Université Libre de Bruxelles), Dong‐Wan Kim, Veerle Surmont, Martin Reck(German Center for Lung Research), Ji‐Youn Han(Moffitt Cancer Center), Esther Holgado Martin, Cristóbal Belda-Iniesta, Yuichiro Oe, Antonio Chella(University of Palermo), Akhil Chopra, G. Robinet, Héctor Soto Parrà, Michael J. Thomas, Parneet Cheema, Nobuyuki Katakami, Wu‐Chou Su(Hospital Universitario Virgen del Rocío), Young‐Chul Kim(CHA University Bundang Medical Center), Juergen Wolf, Jong-Seok Lee(Moffitt Cancer Center), Hideo Saka, Michele Stanislaw Milella, Inmaculada Ramos García, Anne Sibille, Takashi Yokoi, Eun Joo Kang, Shinji Atagi, E. Spaeth-Schwalbe, Makoto Nishio, Fumio Imamura, Nashat Gabrail, Rémi Veillon, Sofie Derijcke, Tadashi Maeda, Dylan M. Zylla, Kendra Kubiak, Armando Santoro, Ma. Noemi Uy, Sarayut Lucien Geater, Antoîne Italiano, Dariusz M. Kowalski, Fabrice Barlési, Yuh‐Min Chen, David R. Spigel, Busyamas Chewaskulyong, Ramón García Gómez, Rosa Álvarez, Chih-Hsin Yang, Te‐Chun Hsia, Fabrice Denis, Hiroshi Sakai, Mark Vincent, Kōichi Goto, Joaquim Bosch‐Barrera, Glen J. Weiss, Jean-Luc Canon, Christian W. Scholz, Massimo Aglietta, Hirotsugu Kemmotsu, Koichi Azuma, Penelope A. Bradbury, Ronald Feld, Abraham Chachoua, Jacek Jassem, Rosalyn A. Juergens, Ramon Palmero Sanchez, Albert Malcolm, Nandagopal Vrindavanam, Kaoru Kubota, Cornelius F. Waller, David Waterhouse, Bruno Coudert, Z. Mark, Miyako Satouchi, Gee‐Chen Chang, Christian Herzmann, Arvind Chaudhry, Selvaraj Giridharan, Paul J. Hesketh(University of Ottawa), Norihiko Ikeda, Ralph V. Boccia, Nichola Iannotti, Missak Haigentz, John A. Reynolds(Carolina BioOncology Institute), J. Marruecos Querol(Carolina BioOncology Institute), Kazuhiko Nakagawa, Shunichi Sugawara, Eng Huat Tan, Tomonori Hirashima, Scott Gettinger, Terufumi Kato, Koji Takeda, Óscar Juan, Andrea Mohn-Staudner, Amit Panwalkar, Davey B. Daniel, Kunihiko Kobayashi, Guia Elena Imelda Ladrera, Clemens Schulte, Martin Sebastian, Markéta Černovská, Helena Čoupková, Libor Havel, Norbert Pauk, Joginder Singh, Shuji Murakami, Tibor Csőszi, György Losonczy, Allan Price(University of Ottawa), Ian C. Anderson, Mussawar Iqbal, Vamsee Torri, Erzsébet Juhász, Saleem Khanani, Leona Koubková, Benjamin Levy, Ray D. Page(Moffitt Cancer Center), Csaba Böcskei, Lucio Crinò, David Einspahr, Christopher Hagenstad, Necy S Juat, Lindsay Overton, Mitchell Garrison, Zsuzsanna Szalai
The Lancet Oncology
March 12, 2018
Cited by 575Open Access
Full Text

Abstract


Related Papers